Gram-negative bacilli are a common cause of infections in hospitalized cancer patients. Consequently, the discovery of new antibiotics with activity against these organisms are of major importance. Cephalosporins have proven to be significantly active against Klebsiella pneumoniae, Escherichia coli, Proteus mirabilis and most gram-positive cocci.1) Since the introduction of cephalothin, numerous derivatives have been synthesized which offer advantages such as oral administration, less toxicity and higher and more prolonged serum concentrations. This study was initiated to evaluate the comparative in vitro activity of the cephalosporins against gram-negative bacilli and gram-positive cocci and to determine whether the increased use of these antibiotics had resulted in the emergence of increasing numbers of resistant organisms.
Materials and Methods
Susceptible testing was conducted on 443 isolates of gram-negative bacilli and gram-positive cocci using a dilution technique with an automatic microtiter system .2.3) The organisms were inoculated into MUELLER-HINTON broth (Difco) and incubated at 37°C for 18 hours. A 0.05-ml sample of 10-3 dilution of the broth cultures of gram-negative bacilli and Staphylococcus aureus (approximately 106 colony forming units/ml) was used as the inoculum for the susceptibility tests. A 0.05-ml sample of a 10-2 dilution of the broth cultures of Diplococcus pneumoniae and Streptococcus pyogenes (approximately 106 colony forming units/ml) was used as the inoculum.
All gram-negative bacilli were isolated from blood specimens of patients between 1967 and 1973. The majority of these patients were hospitalized at this institution and had underlying malignancies. A total of 160 isolates of K. pneumoniae, 130 isolates of E. coli and 88 isolates of P. mirabilis were tested. inhibited only 47 % at a concentration of 6.25 µg/ml. 
